CT 52923
Alternative Names: CT052923Latest Information Update: 08 Jun 2006
At a glance
- Originator Kyowa Hakko; Millennium Pharmaceuticals
- Class Antineoplastics
- Mechanism of Action Platelet-derived growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer